title: Thrombotic events after discontinuing dabigatran: rebound or resumption?
authors: Katie M
authors: KM
authors: Thorne
authors: Stephen
authors: S
authors: Dee
authors: Sisira
authors: S
authors: Jayathissa
mesh_terms: D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D000069604:Dabigatran; D006801:Humans; D008875:Middle Aged; D012008:Recurrence; D013927:Thrombosis / Q000209:etiology* / Q000473:pathology / Q000517:prevention & control; D015091:beta-Alanine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran